Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-09-11
2007-09-11
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S052000, C536S026100, C536S026200, C536S026410, C536S026900, C536S027100, C536S028700
Reexamination Certificate
active
11674954
ABSTRACT:
Nucleosides and nucleotides containing a tricyclic base portion thereof are useful for treating infectious diseases and proliferative disorders, such as viral infections or cancer respectively.
REFERENCES:
patent: 6600028 (2003-07-01), Brown et al.
patent: 2003/0008841 (2003-01-01), Devos et al.
patent: 2006/0252715 (2006-11-01), Keicher et al.
patent: WO 98/43991 (1998-10-01), None
patent: WO 99/43691 (1999-09-01), None
patent: WO 01/32153 (2001-05-01), None
patent: WO 01/60315 (2001-08-01), None
patent: WO 01/79246 (2001-10-01), None
patent: WO 01/90121 (2001-11-01), None
patent: WO 01/92282 (2001-12-01), None
patent: WO 02/18404 (2002-03-01), None
patent: WO 02/057287 (2002-07-01), None
patent: WO 02/057425 (2002-07-01), None
patent: WO 03/061385 (2003-07-01), None
patent: WO 2006/093986 (2006-09-01), None
patent: WO 2006/093987 (2006-09-01), None
U.S. Appl. No. 10/568,917, filed Feb. 2006, Cook.
Silverman, R., The Organic Chemistry of Drug Design and Drug Action, ((1992) published by Academic Press, pp. 19-21 and 352-397.
Poizot-Martin et al., “Efficacy and Tolerance of HCV Treatment in HIV-HCV Coinfected Patients: The Potential Interaction of Pl Treatment” HIV Clinical Trials (2003) vol. 4, No. 4, pp. 262-268.
STN Database Accession No. 847819-10-7, Apr. 3, 2005.
Araujo et al., “Synthesis and Applications of a Tricyclic Analogue of N6-Methoxy-2,6-Diamino-2'-Deoxyriboside”, Collection Symposium Series, 5:328-331, 2002.
Delaney et al., “Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation,” Antiviral Chemistry & Chemotherapy 12(1):1-35, 2001.
Dymock et al., “Novel approaches to the treatment of hepatitis C virus infection,” Antiviral Chemistry & Chemotherapy 11(2):79-96, 2000.
Hill et al., “Synthesis and Polymerase Incorporation Properties of a Tricyclic Pyrrolopyrimidine Related to N6-Hydroxy-2'-Deoxyadenosine”, Nucleosides & Nucleotides 18(4&5):573-574, 1999.
Porcari et al., “Acyclic Sugar Analogs of Triciribine: Lack of Antiviral and Antiproliferative Activity Correlate with Low Intracellular Phosphorylation,” Nucleosides & Nucleotides 18(11&12):2475-2497, 1999.
Porcari et al., “Deoxy Sugar Analogues of Triciribine: Correlation of Antiviral and Antiproliferative Activity with Intracellular Phosphorylation,” J. Med. Chem. 43:2438-2448, 2000.
Porcari et al., “6-N-Acyltriciribine Analogues: Structure-Activity Relationship between Acyl Carbon Chain Length and Activity against HIV-1,” J. Med. Chem. 43:2457-2463, 2000.
Seela et al., “Synthesis of 7-alkynylated 8-aza-7-deaza-2'-deoxyadenosines via the Pd-catalysed cross-coupling reaction”, J. Chem. Soc., Perkin Trans. 1:3233-3239, 1998.
Seela et al., “7-Substituted 7-Deaza-2'-deoxyadenosines and 8-Aza-7-deaza-2'-deoxyadenosines: Fluorescence of DNA-Base Analogues Induced by the 7-Alkynyl Side Chain”, Helvetica Chimica Acta, 83:910-927, 2000.
Williams et al., “Synthesis of a hydrogen-bond-degenerate tricyclic pyrrolopyrimidine nucleoside and of its 5'-triphosphate”, J. Chem. Soc., Perkin Trans. 1:3565-3570, 1998.
Cook Phillip Dan
Ewing, legal representative Deborah K.
Jin Yi
Lambert John
Prhavc Marija
Biota Scientific Management Pty Ltd
Jiang Shaojia Anna
Olson Eric S
Seed IP Law Group PLLC
LandOfFree
Tricyclic nucleosides or nucleotides as therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic nucleosides or nucleotides as therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic nucleosides or nucleotides as therapeutic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3732419